New Imaging-Guided radiation aims to better control High-Risk prostate cancer
NCT ID NCT07291557
First seen Jan 06, 2026 · Last updated May 15, 2026 · Updated 23 times
Summary
This study is for men with high-risk prostate cancer that hasn't spread to lymph nodes. It uses PSMA-PET scans to precisely target radiation to the prostate and nearby tissues, with or without whole pelvis radiation. The goal is to improve cancer control and reduce side effects. About 250 participants will be followed for 5 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cross Cancer Institute
Edmonton, Alberta, T6G 1Z2, Canada
Conditions
Explore the condition pages connected to this study.